GlassScriptPhysician profile
Thien T Ho
NPI 1790212496
$2,005.31
in general payments reported to CMS, 2019-2025
17 companies · $512 in 2025
The $512 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2021: $12.99 · 2022: $30.14 · 2023: $957 · 2024: $361 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,535 · Consulting Fee: $195 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,534.71 |
| Consulting Fee | $195.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $362.20 | 2023 | Veltassa, Korsuva |
| Alexion Pharmaceuticals, INC. | $274.99 | 2024-2025 | Ultomiris, Soliris |
| Calliditas Therapeutics US INC. | $272.56 | 2025 | Tarpeyo |
| Amgen INC. | $229.81 | 2023-2024 | Tavneos |
| Astrazeneca Pharmaceuticals LP | $153.29 | 2024-2025 | Farxiga, Lokelma |
| Aurinia Pharma U.S., INC. | $108.48 | 2023 | Lupkynis |
| Glaxosmithkline, LLC. | $105.75 | 2023 | Benlysta |
| Novartis Pharmaceuticals Corporation | $103.80 | 2023-2025 | |
| Mallinckrodt Hospital Products INC. | $100.22 | 2023 | Terlivaz |
| Nxstage Medical, INC. | $98.60 | 2023 | Nxstage System One |
| Convatec INC. | $67.40 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.14 | 2022 | |
| Allergan, INC. | $29.52 | 2019 | |
| Pfizer INC. | $22.96 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.00 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $12.99 | 2021 | |
| Ethicon US, LLC | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thien Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.